Optimi Health Corp. (OPTHF)

Revance Therapeutics Revenue

Optimi Health had revenue of 61.24K CAD in the quarter ending March 31, 2025, a decrease of -26.12%. This brings the company's revenue in the last twelve months to 495.83K, up 97.24% year-over-year. In the fiscal year ending September 30, 2024, Optimi Health had annual revenue of 389.85K with 115.28% growth.

• Revenue (ttm): 495.83K CAD
• Revenue Growth: +97.24%
• P/S Ratio: 31.38
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 10.82M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	389.85K	208.76K	115.28%
Sep 30, 2023	181.09K	100.37K	124.35%
Sep 30, 2022	80.72K	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	-	-	-